Chapter 86 Negotiation Begins
The day after the meeting, Liu Weiguo led several colleagues from the Medical Insurance Bureau to Qingshan Pharmaceutical in person.
Zhang Yang was a little surprised by the arrival of Liu Weiguo and his entourage. After all, the clinical phase III trial of "Acofenprovir" has not even been completed yet. Is it too early for the Medical Insurance Bureau to come to your door now?
However.
When he saw his old acquaintance Zhou Hai among his entourage, he still received a few of them warmly.
"Mr. Zhang, let me introduce you formally. This is Director Liu Weiguo, deputy director of the 'Drug Bidding and Procurement Department' of the National Medical Insurance Administration."
"Director Liu, this is the CEO of Qingshan Pharmaceutical, Zhang Yang."< br>
"Hello, Director Liu."
Zhang Yang took the initiative to extend his right hand and also took a look at Liu Weiguo.
Liu Weiguo has a Chinese-character face, about fifty years old, and is very energetic, but the hair on his temples is a little gray, which makes him look upright and a bit aged at the same time.
"Hello, Mr. Zhang, I have long admired your name!"
"I heard that you are very young before, but I didn't expect you to be so young. Heroes have always been born in young men since ancient times!"
"Haha, Director Liu You’ve thanked me, please take a seat.”
Everyone takes a seat.
Waiting for the aroma of tea to overflow, Zhang Yang sat directly above him, looking at several medical insurance representatives headed by Director Liu sitting around, he couldn't help but smile:
"Director Liu, I have seen a lot of videos on Douyin of medical insurance representatives and pharmaceutical companies bargaining for prices. I didn't expect that I would also become the protagonist in the video today."
"I hope you will show mercy." ."
After Zhang Yang finished speaking, Liu Weiguo was a little embarrassed by his first words.
The bargaining that Zhang Yang talks about is actually "collective purchasing of medicines."
In 2019, the Medical Insurance Bureau promoted the reform of drug procurement and proposed the concept of "centralized drug procurement" for the first time.
To put it simply, the National Medical Insurance Administration releases relevant drug procurement information, clarifies the drug procurement quantity, and then negotiates with pharmaceutical companies through centralized, exclusive, and volume-based procurement methods.
This method has forced some pharmaceutical companies to reduce the price of drugs that cost hundreds of yuan to tens or even a few yuan in order to enter the centralized purchasing list;
For example, " "Gefitinib Tablets", after entering the centralized purchasing, the price dropped from the initial 2,280 yuan to 547 yuan, a price reduction of 69%.
Another example is the common children’s medicine cefixime granules. After being included in the centralized procurement, the price dropped from the previous 26 yuan per box to 6.67 yuan per box.
In addition, the prices of amlodipine tablets and metformin tablets for treating hypertension and diabetes will also be reduced by about 60%.
but.
"Pharmaceutical centralized purchasing" generally targets conventional drugs and drugs for chronic diseases, and most of them are generic drugs, which can be produced by many domestic pharmaceutical companies.
What about the “Acofenprofovir” developed by Tsingshan Pharmaceutical?
The only drug in the world that can cure hepatitis B.
To put it harshly, if your medical insurance prefers to purchase it or not, it will not affect the sales of "Ekofuvir".
Therefore, he knew very well in his heart that, let alone breaking bones like the "collective medical procurement", it was already thankful that he could talk about the psychologically expected price.
Of course, these words are impossible to say.
As the negotiator of the Medical Insurance Bureau, although Tsingshan Pharmaceutical has an absolute advantage in this negotiation and although he does not have any bargaining chips, his duty and responsibility is to overcome difficulties and do everything possible to lower the purchase price as much as possible. . Thinking of this, Liu Weiguo forced out an awkward smile and did not answer directly.
“Mr. Zhang, you are joking.”
"Actually, we are not willing to bargain with pharmaceutical companies, but after all, this is our responsibility and we have no choice."
Zhang Yang nodded slightly and said no more.
“I understand.”
Seeing this, Liu Weiguo took a deep breath and changed the topic.
“Well, thank you for your understanding. Mr. Zhang, let’s get into the topic directly.”
"You also know that the main purpose of our visit today is to learn about the 'Ixafenprofovir' that your company has just developed and can cure hepatitis B virus."
"As we all know, there are currently 120 million people in our country. Hepatitis B 80% of them are patients born between 1980 and 1995. The current group of people are between the ages of 30 and 45. They are the backbone of every family.”
< br>"And as time goes by As time goes by, most of these people have been infected for ten or even twenty years, and the harm of hepatitis B virus has gradually appeared in them."
"Fortunately, you developed this drug that can cure hepatitis B in time. Medicine, so you have not only saved this generation, but also tens of millions of families."
As he spoke, Liu Weiguo's expression became serious, and he slowly stood up from his chair, and then. Bowed deeply to Zhang Yang.
"On behalf of all hepatitis B patients across the country, I would like to thank you for developing this drug that can cure hepatitis B. You have saved countless people."
The sudden action made Zhang Yang stunned for a moment, but after hearing the words clearly, he felt Still feeling warm,
he suddenly thought of the copy in the previous simulator - the fate of a generation.
Is this considered a change in the destiny of this generation?
Not only Zhang Yang, but also Zhou Hai, who was accompanying him, was a little surprised by Liu Weiguo's sudden movement and couldn't help but look at Liu Weiguo twice.
"Director Liu, you're welcome. Sit down and talk."
"Yes."
Under Zhang Yang's persuasion, Liu Weiguo sat back on the chair.
After sighing slightly, he took out a piece of paper information from the briefcase he carried with him and placed it in front of Zhang Yang.
“In fact, the country has always attached great importance to the situation of hepatitis B patients in recent years.”
"This information is a 'statistical table on the outpatient treatment received by hepatitis B patients in the past ten years' that I got from the Statistics Department of the National Health Commission."
"You first look at the year before 2019, which is just now Before the 'centralized procurement of medicines' you mentioned, the statistical data at that time were accepted by the whole country. Only 10 million hepatitis B patients are treated in regular hospitals. "
"Only 10 million of the 120 million patients receive treatment, less than one tenth. Guess the reason? "< br>
Zhang Yang looked down at the data and said nothing.
Seeing this, Liu Weiguo continued:
"If I remember correctly, the best hepatitis B treatment drug at that time was 'tenofovir disoproxil', which is tenofovir. The price of the original drug was 999 yuan per box, one box per month."
< br>“Even domestic generic drugs were priced as high as 490 yuan at that time.”
“According to the ‘National Hepatitis B Prevention and Control Guidelines’, hepatitis B patients must undergo a reexamination every three months, and the content of the examination must be Including liver function (biochemistry), abdominal color ultrasound, etc., the cost of these two examinations was close to 300 yuan.”
“In addition, a box of generic drugs was as high as 490 yuan at that time, and the cost of three months of medication increased. The cost of the examination alone is 2,000 yuan.”
“I think you have your own answer as to whether 2,000 yuan for three months is a lot for ordinary people.”
...
PS: Thanks to QQ book friend Quan Shuyou for the big 100-coin reward!
(End of this chapter)